Showing results (1731-1740 of 2,100) with videos related to

Sort By:
Pageof 210
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancerJ C Osorio, A Ni, J E Chaft, et al.
American Journal of Hematology|July 8, 2015
Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group studySebastian Grosicki, Jerzy Holowiecki, Kazimierz Kuliczkowski, et al.
European Journal of Haematology|January 26, 1999
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in PolandT Robak, M Błasińska-Morawiec, J Błoński, et al.
Elife|March 13, 2020
HIPK4 is essential for murine spermiogenesisJ Aaron Crapster, Paul G Rack, Zane J Hellmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Potential ecological impacts of climate intervention by reflecting sunlight to cool EarthPhoebe L Zarnetske, Jessica Gurevitch, Janet Franklin, et al.
Journal for Immunotherapy of Cancer|March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapyNaiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.
European Journal of Haematology|October 24, 1997
2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseasesT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Gynecologic Oncology|March 27, 2016
Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancersLorna Rodriguez-Rodriguez, Kim M Hirshfield, Veronica Rojas, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance statusJoao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.
Thrombosis Research|November 29, 2015
Efficacy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (VONCENTO®) in subjects with haemophilia A (SWIFT-HA study)Aleksander Skotnicki, Toshko J Lissitchkov, Vasily Mamonov, et al.
Pageof 210